EUVIMEDEUVIMED entdecken
Open Access

Tripartite Motif-containing 22 Is Involved in TLR3-mediated Inflammatory Pathway in Rheumatoid Fibroblast-like Synoviocytes

Kairo Wada, Hikaru Kristi Ishibashi, Yuzuru Nakamura, Tatsuro Saruga, Tadaatsu Imaizumi, Akira Kurose, Mayuki Tachizaki, Shogo Kawaguchi, Kazuhiko Seya, Kazuki Oishi, Eiji Sasaki, Kanichiro Wada und 1 weitere

In Vivo · 2025

DOI: 10.21873/invivo.14123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2025. Verfasst von Kairo Wada und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Japan; h22gm126@hiroskai-u.ac.jp wadakai0909@outlook.jp. Hauptthemen laut MEDLINE: Toll-Like Receptor 3, Synoviocytes, Arthritis, Rheumatoid, Inflammation. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Rheumatoid arthritis (RA) is an autoimmune disease characterized by synovial inflammation and cartilage destruction. Tripartite motif-containing 22 (TRIM22) is involved in intracellular signal transduction, protein regulation, and innate immunity through E3 ubiquitin ligase activity. In this study, we examined the expression of TRIM22 and its potential role in synovial inflammation in RA. MATERIALS AND METHODS: Human rheumatoid fibroblast-like synoviocytes (RFLS) were cultured and treated with polyinosinic:polycytidylic acid (poly I:C), a toll-like receptor 3 (TLR3) ligand. Poly I:C was applied at different concentrations for different treatment durations. RNA interference was performed by pre-treating RFLS with either non-silencing control small interfering RNA (siRNA) or siRNA targeting TRIM22, interferon β (IFNB), and nuclear factor-kappa B (NFKB) p65. TRIM22 expression in RA synovial tissue was analyzed by immunohistochemistry. RESULTS: TRIM22 expression in RFLS was induced by poly I:C in a concentration and time-dependent manner, and TRIM22 and C-C motif chemokine ligand 5 (CCL5) were regulated by IFN-β and NF-κB pathways. TRIM22 knockdown reduced poly I:C-induced expression of CCL5 and IFN-β. Immunohistochemistry confirmed higher TRIM22 expression in RA synovial tissue compared to osteoarthritis tissue. CONCLUSION: Treatment of cultured RFLS with a TLR3 agonist led to the upregulation of TRIM22 expression. TRIM22 is regulated through the IFN-β and NF-κB-mediated pathways and TRIM22 positively regulates poly I:C-induced CCL5 and IFN-β expression. TRIM22 may have an important role in synovial inflammation associated with RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 3SynoviocytesArthritis, RheumatoidInflammationRepressor ProteinsHumansSignal TransductionFibroblastsPoly I-CInterferon-betaNF-kappa BTripartite Motif ProteinsCells, CulturedSynovial MembraneChemokine CCL5Gene Expression RegulationMinor Histocompatibility Antigens

Stichwörter der Autor:innen

C-C motif chemokine ligand 5Rheumatoid arthritisrheumatoid fibroblast-like synoviocytestoll-like receptor 3tripartite motif-containing 22

Substanzen

Toll-Like Receptor 3TLR3 protein, humanPoly I-CTRIM22 protein, humanRepressor ProteinsInterferon-betaNF-kappa BTripartite Motif ProteinsChemokine CCL5Minor Histocompatibility Antigens

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Japan; h22gm126@hiroskai-u.ac.jp wadakai0909@outlook.jp.
  • Department of Orthopaedic Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Department of Vascular and Inflammatory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Department of Anatomic Pathology, Hirosaki University Graduate School of Medicine, Aomori, Japan.

Zitieren

APA

Wada, K., Ishibashi, H. K., Nakamura, Y., Saruga, T., Imaizumi, T., Kurose, A., Tachizaki, M., Kawaguchi, S., Seya, K., Oishi, K., Sasaki, E., Wada, K., & Ishibashi, Y. (2025). Tripartite Motif-containing 22 Is Involved in TLR3-mediated Inflammatory Pathway in Rheumatoid Fibroblast-like Synoviocytes. In Vivo. https://doi.org/10.21873/invivo.14123

Vancouver

Wada K, Ishibashi HK, Nakamura Y, Saruga T, Imaizumi T, Kurose A, et al. Tripartite Motif-containing 22 Is Involved in TLR3-mediated Inflammatory Pathway in Rheumatoid Fibroblast-like Synoviocytes. In Vivo. 2025. doi:10.21873/invivo.14123

BibTeX
@article{Wada2025,
  author = {Wada, Kairo and Ishibashi, Hikaru Kristi and Nakamura, Yuzuru and Saruga, Tatsuro and Imaizumi, Tadaatsu and Kurose, Akira and Tachizaki, Mayuki and Kawaguchi, Shogo and Seya, Kazuhiko and Oishi, Kazuki and Sasaki, Eiji and Wada, Kanichiro and Ishibashi, Yasuyuki},
  title = {Tripartite Motif-containing 22 Is Involved in TLR3-mediated Inflammatory Pathway in Rheumatoid Fibroblast-like Synoviocytes},
  journal = {In Vivo},
  year = {2025},
  doi = {10.21873/invivo.14123}
}
Kostenlos starten →